R&D Solutions net new bookings measure newly booked clinical-research work on IQVIA's basis after the effects included in its net-bookings methodology.
IQVIA reported $3.15B of Q2 2026 net new bookings, up 19% year over year. Last-twelve-month net new bookings were $11.3B, up 13%.
Orders are not revenue
Bookings enter the future-work funnel before contracted backlog converts into R&D Solutions revenue. The timing can span multiple periods and is exposed to trial changes and cancellations.
Compare quarterly bookings with the book-to-bill ratio rather than assuming a booking dollar becomes a revenue dollar immediately.
Primary sources: IQVIA Q2 2026 Form 10-Q and Q2 2026 earnings release filed with the SEC.
Continue Research
Continue from the concept into the Grizzly Bulls research surface that best matches the next question. These links are research continuations, not recommendations or required steps.
Compare stocks
Compare new clinical-research contract awards without treating bookings as current-period revenue.
Explore more topics in the Financial Research Encyclopedia.